OBJECTIVES The aim of this study was to explore whether the use of bleeding avoidance strategies (BAS) explains variability in hospital-level bleeding following percutaneous coronary intervention.
, data on the use of BAS such as radial access, bivalirudin, and potentially vascular closure devices across hospitals is limited. The available data demonstrate that BAS are used in patients at low risk for bleeding rather than in patients most likely to benefita "risk-treatment" paradox (10,13)-however, there may be other unmeasured care processes that affect hospital-level bleeding rates, such as antithrombotic drug dosing, manual compression protocols, and the use of ultrasound-guided femoral access. To date, no large-scale study has compared the association between BAS use and hospital-level bleeding rates and the extent to which individual patient risk and the use of specific BAS may explain the hospital-level variation in observed post-procedural bleeding. Therefore, we used data from the CathPCI Registry to: 1) determine hospital-level variation in observed bleeding rates following PCI; 2) evaluate the extent to which the use of specific BAS may explain the variance in bleeding rates across hospitals; and 3) assess the relationship between hospital-level BAS use and bleeding rates.
We hypothesized that there would be significant variation in hospital-level post-PCI bleeding rates, that some of this variation would be explained by patient risk and the use of BAS, and that high use of BAS would be associated with lower rates of bleeding. We excluded patients with missing variables necessary to define bleeding (n ¼ 10,210) and those who underwent coronary artery bypass grafting (n ¼ 30,238).
METHODS
We further excluded patients undergoing PCI at sites that reported no bleeding events (n ¼ 13,752); patients who had contraindications to, were blinded to, or had missing information for bivalirudin administration (n ¼ 2,573); and patients who presented at hospitals performing <50 PCIs annually (n ¼ 478).
DATA DEFINITIONS AND OUTCOMES. Patients were treated using any BAS if: 1) they underwent PCI via radial artery access; 2) bivalirudin was used for Vora et al.
Bleeding Avoidance Strategies and Hospital-Level Variation The observed rate of bleeding for each hospital was calculated as the observed number of bleeding events divided by the total number of admissions. To estimate adjusted hospital bleeding rates by patient risk, we used logistic regression with random intercepts for hospital. The log odds for random hospital were assumed to be normally distributed, with mean equal to the intercept and variance equal to the randomeffect variance or variation in log odds attributable to between-hospital differences. We estimated these parameters and transformed from the log-odds scale to the probability scale. The hospital-specific intercepts were used to estimate hospital-specific bleeding rates.
To assess whether the use of BAS attenuates the variation in adjusted hospital-level bleeding rates, we fit a series of 8 models and estimated random- Study population characteristics, including exclusions. CABG ¼ coronary artery bypass grafting; PCI ¼ percutaneous coronary intervention.
Vora et al. Vora et al. Hospital characteristics by tertile of BAS use are described in Table 2 . The lowest tertile hospitals were larger with a higher average annual PCI volume than the highest tertile hospitals. Hospital location setting and affiliation were modestly but statistically different across groups.
HOSPITAL-LEVEL VARIATION IN BLEEDING RATES
AND THE INFLUENCE OF BAS USE. There was significant variation in unadjusted bleeding rates across hospitals ( Figure 2) . The median hospital rate of bleeding was 5.0% (IQR: 3.65% to 6.56%), but wide variation, with a hospital bleeding rate of 2.12% in the 5th percentile but 9.84% in the 95th percentile. After risk adjustment that incorporated individual bleeding risk using the CathPCI bleeding risk model (15) and accounting for in-hospital clustering, the median hospital bleeding rate was similar (5.14%; IQR: 4.00% to 6.60%), with a similar range (5th percentile 2.65%, 95th percentile 9.36%).
We created a series of mixed-effects models to estimate the hospital-level variance in bleeding across the spectrum of the different BAS and calculated the PCV compared with the unadjusted model (model 1) ( Table 3) . After adjusting for patient risk factors using the CathPCI bleeding risk model (model 2), the PCV in bleeding rates across hospitals decreased by 20%. However, the addition of any individual BAS use or a combination of the various BAS options (models 3 to 8) only modestly explained the variation of bleeding rates, and more than 70% of the variation in bleeding remained unexplained, even after adjustment for patient risk factors and BAS use. Values are median (interquartile range) or %. All p < 0.001.
PCI ¼ percutaneous coronary intervention.
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Vora et al. In this context, it is important to determine if variation in post-PCI bleeding rates is due simply to differences in patient mix across hospitals, variation in the application of BAS (i.e., the risk-treatment paradox), both, or some unmeasured factor(s). We found that patient-level factors and BAS use explained only 26% of the overall variation in bleeding rates across hospitals. However, patients receiving BAS were at lower predicted risk for bleeding than patients not receiving BAS. This suggests that a significant proportion of hospitals may be using BAS in patients at relatively low risk, despite the likelihood of increased benefit in high-risk patients as described by Marso et al. (10) . Among hospitals that used BAS in more than 85% of patients, however, we observed lower rates of overall bleeding, demonstrating that a strategy to broadly use BAS in all patients (i.e., overcoming the risk-treatment paradox) is a reasonable strategy to reduce overall variation in hospital bleeding rates.
As PCI-related bleeding becomes more prominent as a potential hospital quality indicator, it will be important to ensure that hospital bleeding rates are standardized according to patient risk. However, our analysis demonstrates that even after taking patient Adjusted spline plot predicting rates of bleeding by percentage of bleeding avoidance strategies (BAS) used. The vertical lines represent the spline knots at the 5th, 35th, 65th, and 95th percentiles of % any BAS.
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PERSPECTIVES
WHAT IS KNOWN? Previous studies have shown significant variation in bleeding rates following PCI across hospitals, but the extent to which using BAS explains this variation is unknown.
WHAT IS NEW?
We demonstrate that about 1 in 20 patients undergoing PCI had bleeding events.
Although there was wide hospital-level variation in bleeding, patient factors explained only 20% of this variation, and the use of radial access and bivalirudin only explained another 7.8% of the variation.
More than 70% of the variation in bleeding remains unexplained.
WHAT IS NEXT? This study urges caution in the use of post-PCI bleeding as a performance measure, as a significant proportion of the hospital-level variation in bleeding remains unexplained. More granular data collection and further analyses are necessary to explain this variation in bleeding rates to develop best practices to mitigate bleeding following PCI.
Vora et al.
